Monroe Capital (MRCC) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
16 Dec, 2025Executive summary
Adjusted Net Investment Income for Q4 2024 was $6.2 million ($0.29/share), covering the $0.25/share dividend and resulting in an 11.4% annualized dividend yield at the February 28, 2025, share price.
NAV declined 3.6% to $191.8 million ($8.85/share) as of December 31, 2024, mainly due to net unrealized losses from a specific portfolio company.
Portfolio companies showed healthy revenue and EBITDA growth, benefiting from a positive economic backdrop, declining rates, and steadying inflation.
Shareholders approved a new investment advisory agreement as part of the Wendel Group partnership, with no changes to terms or operations.
Monroe Capital Corporation manages $19.4B in AUM, focusing on private credit and lower middle market lending, with a strong track record and industry recognition.
Financial highlights
Investment portfolio totaled $457 million at year-end, down from $474.3 million in the prior quarter.
Q4 total investment income was $14 million, down from $15.7 million in Q3, mainly due to lower base rates and a new non-accrual.
Total expenses for Q4 were $8 million, down from $9.2 million in Q3, driven by lower interest and debt financing costs.
Net loss on the portfolio for Q4 was $7.7 million, primarily from an unrealized mark-to-market loss on a specific asset.
Weighted average effective yield on debt and preferred equity investments was 10.2%, down from 11% in the prior quarter.
Outlook and guidance
Management expects incentive fee limitations to persist into the next quarter due to the total return requirement.
Anticipates a more active deal environment in 2025, supported by lower rates, improved economic outlook, and increased sponsor M&A activity.
Plans to grow the portfolio and pursue new investment opportunities in 2025 after right-sizing and cleaning up legacy assets.
Portfolio continues to target high-quality, diversified first lien loans with low leverage and strong covenants, aiming for predictable returns.
Capital redeployment will be selective, with ongoing attention to risk-adjusted returns.
Latest events from Monroe Capital
- Both asset sale and merger proposals were approved by a majority of outstanding shares.MRCC
EGM 202613 Mar 2026 - Supplemental distributions and enhanced merger terms were approved to address shareholder concerns.MRCC
Proxy Filing11 Mar 2026 - Supplement updates proxy materials for a proposed transaction, referencing recent filings.MRCC
Proxy Filing6 Mar 2026 - Net investment income and NAV declined year-over-year, with merger expected to unlock value.MRCC
Q4 20255 Mar 2026 - Director election and share sale authorization approved; no shareholder questions raised.MRCC
AGM 20243 Feb 2026 - Adjusted NII rose to $0.31/share, covering the dividend as NAV and leverage declined.MRCC
Q2 20242 Feb 2026 - Shareholders to vote on merger and asset sale, with NAV-based share exchange and fee waiver.MRCC
Proxy Filing20 Jan 2026 - Dividend coverage strong, NAV dipped, non-accruals up, Wendel partnership adds $1B capital.MRCC
Q3 202414 Jan 2026 - Shareholders to vote on unchanged advisory agreement after Wendel acquires 75% of Monroe.MRCC
Proxy Filing2 Dec 2025